|
|
||||||||
Neurology, Vol 45, Issue 2 374-376, Copyright © 1995 by American Academy of Neurology
ARTICLES |
DW Kimmel, EF Wijdicks and M Rodriguez
Department of Neurology, Mayo Clinic, Rochester, MN 55905.
Cerebral demyelinating disease developed in a patient during adjuvant therapy with levamisole for malignant melanoma. This patient had no evidence of previous neurologic disease. Levamisole was administered for 5 weeks (total dose, 1,500 mg). Over a period of 3 weeks, the patient became progressively confused and ataxic. MRI with gadolinium enhancement demonstrated prominent multifocal enhancing white matter lesions. CSF examination revealed an inflammatory profile. After discontinuation of treatment with levamisole and a short course of corticosteroid therapy, the patient's condition dramatically improved. MRI also indicated improvement. Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received 5-fluorouracil and levamisole may have been caused at least partly by levamisole.
This article has been cited by other articles:
![]() |
H. M. Liu, W. J. Hsieh, C. C. Yang, V. C. Wu, and K. D. Wu Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers. Neurology, September 26, 2006; 67(6): 1065 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kumar, R. Orenstein, D. Z. Uslan, E. F. Berbari, C. J. Klein, and A. J. Windebank Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis Neurology, April 11, 2006; 66(7): 1120 - 1121. [Full Text] [PDF] |
||||
![]() |
D. A. Franco and H. S. Greenberg 5-FU multifocal inflammatory leukoencephalopathy and dihydropyrimidine dehydrogenase deficiency Neurology, January 9, 2001; 56(1): 110 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Recht and J. M. Primavera Case 24-1999- Neurologic Disorder in a 65-Year-Old Man after Treatment of Colon Cancer N. Engl. J. Med., August 12, 1999; 341(7): 512 - 519. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |